MALAT1 and Miyoshi myopathy: In this light, we here demonstrated that gymnotic delivery of MALAT1-targeting 16mer LNA gapmeR g#5 is a potent anti-MM agent that decreases cell proliferation even in the presence of the BM milieu, and triggers apoptosis in both MM cell lines and patient-derived PCs.